Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Sevelamer Hydrochloride (atc Code According To Who 2027-01-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Sevelamer Hydrochloride (atc Code According To Who: V03ae02) 2027-01-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Sevelamer Hydrochloride (atc Code According To Who: V03ae02) 2027-01-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Sevelamer Hydrochloride (atc Code According To Who: V03ae02) 2027-01-31
Germany Conclusion Not Exclusive Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Beclometasonformoterolglycopyrronium (atc Code According To Who 2027-01-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement According To Ss 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium (atc Code According To Who: R03al09) 2027-01-31
Germany Azelastine/fluticasone Propionate_tk, Hek, Hkk 2027-01-31
Germany Valsartan/indapamide_tk, Hkk 2027-01-31
Germany Telmisartan/amlodipine_tc, Heck, Hcc 2027-01-31
Germany Xylometazoline_tk, Hek, Hkk 2027-01-31
Whats app